Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Mar 15;11(3):290-7.
doi: 10.1016/j.chom.2012.01.016.

DAI/ZBP1/DLM-1 complexes with RIP3 to mediate virus-induced programmed necrosis that is targeted by murine cytomegalovirus vIRA

Affiliations

DAI/ZBP1/DLM-1 complexes with RIP3 to mediate virus-induced programmed necrosis that is targeted by murine cytomegalovirus vIRA

Jason W Upton et al. Cell Host Microbe. .

Abstract

Programmed necrosis, like apoptosis, eliminates pathogen-infected cells as a component of host defense. Receptor-interacting protein kinase (RIP) 3 (also called RIPK3) mediates RIP homotypic interaction motif (RHIM)-dependent programmed necrosis induced by murine cytomegalovirus (MCMV) infection or death receptor activation and suppressed by the MCMV-encoded viral inhibitor of RIP activation (vIRA). We find that interferon-independent expression of DNA-dependent activator of interferon regulatory factors (DAI, also known as ZBP1 or DLM-1) sensitizes cells to virus-induced necrosis and that DAI knockdown or knockout cells are resistant to this death pathway. Importantly, as with RIP3(-/-) mice, vIRA mutant MCMV pathogenesis is restored in DAI(-/-) mice, consistent with a DAI-RIP3 complex being the natural target of vIRA. Thus, DAI interacts with RIP3 to mediate virus-induced necrosis analogous to the RIP1-RIP3 complex controlling death receptor-induced necroptosis. These studies unveil a role for DAI as the RIP3 partner mediating virus-induced necrosis.

PubMed Disclaimer

Figures

Figure 1
Figure 1. RIP3 levels differentially confer susceptibility to necroptosis and virus-induced programmed necrosis
(A) Immunoblot (IB) analysis to detect RIP3, RIP1 and β-actin from NIH3T3 cells stably expressing 3XFLAG-tagged RIP3, RIP3mRHIM, or control. (B) Viability of RIP3-expressing NIH3T3 stable cell lines infected with M45mutRHIM MCMV at a multiplicity of infection (MOI) of 10. (n=4) (C) Viability of RIP3-expressing NIH3T3 stable cell lines after treatment with TNF (25 ng/ml) and zVAD-fmk (50 μM) to induce necroptosis (n=3–4). (D) Viability of NIH3T3, 3T3-SA and SVEC4-10 cell lines infected with M45mutRHIM MCMV (MOI=10). (n=3–7) (E) IB analysis of uninfected NIH3T3, 3T3-SA, and SVEC4-10 cells to detect DAI, RIP3, RIP1, and β-actin. A non-specific (*ns) band is characteristic for this antibody (Karayel et al., 2009). **p<0.001, #not significant (p>0.05). See also related Figure S1.
Figure 2
Figure 2. Increased DAI expression sensitizes resistant cells to virus-induced necrosis
(A) IB analysis to detect FLAG and β-actin of NIH3T3 stable cells expressing FLAG-tagged WT DAI, FLAG-tagged DAImRHIM, or control. (B) Viability of DAI-expressing NIH3T3 stable cell lines infected with M45mutRHIM MCMV (MOI=10) and treated with DMSO or Nec-1 (30 μM). (n=4) (C) IB analysis to detect FLAG, RIP3, RIP1 and β-actin in stable NIH3T3 cell lines expressing FLAG-tagged WT DAI together with either a scramble control (Sc) or one of two RIP3-specific shRNAs (RIP3-A or RIP3-B). (D) Viability of DAI-expressing, RIP3 knockdown NIH3T3 stable cell lines following infection with M45mutRHIM MCMV (MOI=10)(n=3). **p<0.001, #not significant (p>0.05). See also related Figure S2.
Figure 3
Figure 3. DAI and RIP3 cooperate in virus-induced necrosis
(A) RIP3 and DAI interaction in the absence of vIRA. IB of immunoprecipitations (IP) and whole cell lysates (WCL; 5% total) showing DAI, M45, RIP3 and β-actin in 3T3-SA cells infected with M45mutRHIM MCMV (MOI=5) harvested at the indicated times (h.p.i.). (B) IB analysis to detect DAI, RIP3, RIP1 and β-actin in 3T3-SA cells transfected with non-targeting (NT) control, DAI, or RIP3 siRNAs (C) Viability of 3T3-SA cells transfected with the indicated siRNA and infected with M45mutRHIM (MOI=10) and treated with DMSO control or Nec-1 inhibitor (30μM). (n=4) (D) IB analysis to detect DAI, RIP3, RIP1, and β-actin in C57BL/6 control, DAI−/−, and RIP3−/− murine embryonic fibroblasts (MEFs) (E) Viability of C57BL/6 control, DAI−/−, and RIP3−/− MEFs infected with M45mutRHIM MCMV (MOI=10)(n=3). (F) Single-step replication of WT and M45mutRHIM MCMV (MOI of 5) on control C57BL/6 (left) and DAI−/− (right) MEFs. Viral titers determined by plaque assay with the first (0 h) time point representing amount of virus in the inoculum. Error bars, SD. *p<0.01, **p<0.001, #not significant (p>0.05). See also related Figure S3.
Figure 4
Figure 4. M45mutRHIM virus attenuation in vivo is reversed in DAI−/− mice
(A) Footpad swelling induced by parental WT or M45mutRHIM MCMV infection. Footpad thickness of C57BL/6 control (top) and DAI−/− (bottom) mice inoculated with 106 pfu was measured with a digital caliper, and mean values plotted at the indicated times over a 14 day time course (n=7–9 animals/group). (B–D) Viral titers from spleen (B), liver (C), and SGs (D) of control (C57BL/6), RIP3−/−, and DAI−/− mice infected via intraperitoneal inoculation with 106 pfu of indicated virus and harvested at the indicated time (n= 5–10 animals/group). Error bars, SEM. See also related Figure S4.

Comment in

References

    1. Barber GN. Cytoplasmic DNA innate immune pathways. Immunological reviews. 2011;243:99–108. - PubMed
    1. Benedict CA, Angulo A, Patterson G, Ha S, Huang H, Messerle M, Ware CF, Ghazal P. Neutrality of the canonical NF-kappaB-dependent pathway for human and murine cytomegalovirus transcription and replication in vitro. J Virol. 2004;78:741–750. - PMC - PubMed
    1. Best SM. Viral subversion of apoptotic enzymes: escape from death row. Annual review of microbiology. 2008;62:171–192. - PMC - PubMed
    1. Brune W, Menard C, Heesemann J, Koszinowski UH. A ribonucleotide reductase homolog of cytomegalovirus and endothelial cell tropism. Science. 2001;291:303–305. - PubMed
    1. Burke JR, Pattoli MA, Gregor KR, Brassil PJ, MacMaster JF, McIntyre KW, Yang X, Iotzova VS, Clarke W, Strnad J, et al. BMS-345541 is a highly selective inhibitor of I kappa B kinase that binds at an allosteric site of the enzyme and blocks NF-kappa B-dependent transcription in mice. J Biol Chem. 2003;278:1450–1456. - PubMed

Publication types

MeSH terms